Revolutionising Neurodegenerative Disease Treatment: Insights from Nevrargenics Investor Presentation in London! We had an incredible opportunity to present Nevrargenics, our ground-breaking neuroscience company, at a prestigious event in London County Hall, right across from the iconic Big Ben and next to St Thomas's Hospital! Proudly hosted by Stakeholderz, the event brought together a dynamic group of investors eager to learn about our game-changing approach to neurodegenerative disease treatment. Neurodegenerative diseases affect over a billion people worldwide, imposing a significant human and economic burden. At Nevrargenics, we're on a mission to revolutionise the field with our cutting-edge technology, which is the result of 20 years of world-leading research conducted at Durham and Aberdeen Universities. Our lead drug candidate, based on our technology of modulating Retinoic Acid Receptors, has the potential to not only treat but also reverse neurodegenerative diseases through neurorepair - a truly unprecedented breakthrough! Backed by a vast intellectual property library, our approach represents a new era in drug development, offering immense promise for disruptive advancements in disease treatment. But we can't do it alone. We're seeking visionary investors to join us on this journey as we embark on the next phase of our development. We are now looking to secure $5m to fund manufacturing and trials for our lead drug, as well as the development of second-generation therapies. And the timing couldn't be better - Phase I/IIa trials have been green-lighted by the UK Regulator MHRA, meaning that human results will be available within a year, marking a potentially significant value creation and inflection point. What's more, Nevrargenics has already caught the attention of Big Pharma players, who will be our ultimate partners in drug development and commercialisation. From Westminster opposite the House of Parliament and on the river Thames, we're not just making waves in the industry - we're doing it with a view! Support Nevrargenics today and be part of the future of neurodegenerative disease treatment. Together, we can make a difference and transform lives around the world. #neuroscience #neurodegeneration #pharmaceuticals #biotechnology #drugs #als #ftd #parkinsons #alzheimers #ms #multiplesclerosis #neuroprotection #nevrargenics #research #drugdevelopment #treatment #therapy #clinical #trials
-
+1